Cancer Therapeutics Startup Earli on China Biotech Lead

Cyriac Roeding, the CEO of cancer therapeutics startup Earli, recently shared his views on China's biotech advancements, confirming his earlier prediction that China would become a major competitor to the US in this field. This insight comes from an interview on Bloomberg's The China Show, where Roeding highlights the significant progress China has made in biotech over the past decade. The discussion underscores the global shift in biotech leadership and the increasing importance of international collaborations in advancing cancer treatments.